It is just over a year since Elkstone closed its €100 million early-stage investment fund for start-ups. The firm describes itself as sector agnostic and you need not look too far for proof of that. Its portfolio ranges from food delivery in Flipdish to fintech in Prommt. But Niall McEvoy, a partner at the firm and formerly of Enterprise Ireland, is keen to do more in the medtech space. “We’re looking at more medtech at the moment as well. We have a great network of advisers around us on the medtech side. We have a great portfolio of medtech investments…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .